Caplin Point Laboratories Limited (BOM:524742)
India · Delayed Price · Currency is INR 2,006.10
-27.00 (-1.33%)
At close: Nov 3, 2025
Caplin Point Laboratories Employees
Caplin Point Laboratories had 3,966 employees as of March 31, 2025. The number of employees increased by 560 or 16.44% compared to the previous year.
Employees
3,966
Change (1Y)
560
Growth (1Y)
16.44%
Revenue / Employee
5.01M INR
Profits / Employee
1.42M INR
Market Cap
152.49B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3,966 | 560 | 16.44% |
| Mar 31, 2024 | 3,406 | 1,764 | 107.43% |
| Mar 31, 2023 | 1,642 | -1,358 | -45.27% |
| Mar 31, 2022 | 3,000 | 1,325 | 79.10% |
| Mar 31, 2021 | 1,675 | -21 | -1.24% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tata Consultancy Services | 607,979 |
| Reliance Industries | 403,303 |
| Infosys | 323,578 |
| State Bank of India | 236,226 |
| HDFC Bank | 214,521 |
| ICICI Bank | 182,665 |
| Life Insurance Corporation of India | 91,606 |
| Bajaj Finance | 64,092 |
Caplin Point Laboratories News
- 2 months ago - Caplin Point subsidiary gets USFDA nod for Milrinone Lactate in 5% Dextrose Injection - Business Upturn
- 3 months ago - Caplin Point shares surge 5% as Q1 revenue jumps 11% YoY to Rs 510 crore, net profit up 23.2% YoY - Business Upturn
- 5 months ago - Caplin Point subsidiary to acquire Mexican pharma firm Triwin Pharma S.A. DE C.V. - Business Upturn
- 6 months ago - Caplin Point Q4 results: Revenue up 10.9% YoY to Rs 502.45 crore, Net profit rises 19.8% YoY - Business Upturn
- 6 months ago - Caplin Point Laboratories subsidiary receives USFDA approval for Haloperidol Decanoate Injection - Business Upturn
- 6 months ago - Caplin Point subsidiary Caplin Steriles gets USFDA approval for Phytonadione Injectable Emulsion - Business Upturn
- 7 months ago - Caplin Point Laboratories shares jump over 3% after acquiring Neoethicals Chile SpA - Business Upturn
- 8 months ago - Caplin Point subsidiary secures USFDA approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution - Business Upturn